|
1
|
Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine.
|
Proc Natl Acad Sci U S A
|
2010
|
3.86
|
|
2
|
Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial.
|
Am J Respir Crit Care Med
|
2014
|
3.10
|
|
3
|
Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia.
|
Blood
|
2012
|
2.65
|
|
4
|
Genome-wide methylation profiling in decitabine-treated patients with acute myeloid leukemia.
|
Blood
|
2012
|
1.97
|
|
5
|
Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia.
|
Blood
|
2012
|
1.51
|
|
6
|
Dose escalation of lenalidomide in relapsed or refractory acute leukemias.
|
J Clin Oncol
|
2010
|
1.20
|
|
7
|
Embryo research and fertilisation code.
|
BMJ
|
1991
|
1.07
|
|
8
|
Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia.
|
Blood
|
2012
|
1.04
|
|
9
|
Impact of molecular prognostic factors in cytogenetically normal acute myeloid leukemia at diagnosis and relapse.
|
Haematologica
|
2011
|
1.00
|
|
10
|
Clinical and laboratory studies of the novel cyclin-dependent kinase inhibitor dinaciclib (SCH 727965) in acute leukemias.
|
Cancer Chemother Pharmacol
|
2013
|
0.88
|
|
11
|
A phase I study of decitabine and rapamycin in relapsed/refractory AML.
|
Leuk Res
|
2013
|
0.83
|
|
12
|
Supportive care needs of women with breast cancer in rural Scotland.
|
Support Care Cancer
|
2014
|
0.82
|
|
13
|
Therapy-related pro-B cell acute lymphoblastic leukemia: report of two patients with MLL amplification.
|
Cancer Genet
|
2012
|
0.82
|
|
14
|
In vivo quantification of active decitabine-triphosphate metabolite: a novel pharmacoanalytical endpoint for optimization of hypomethylating therapy in acute myeloid leukemia.
|
AAPS J
|
2012
|
0.80
|
|
15
|
Differential brain and body temperature during cardiopulmonary bypass--a randomised clinical study.
|
Eur J Cardiothorac Surg
|
2004
|
0.77
|
|
16
|
Use of activated recombinant factor VII in pediatric extracorporeal membrane oxygenation.
|
Pediatr Crit Care Med
|
2010
|
0.75
|
|
17
|
Medical and prehospital care training in UK fire and rescue services.
|
Emerg Med J
|
2010
|
0.75
|
|
18
|
Bringing public health information together.
|
BMJ
|
2007
|
0.75
|